Amedisys (NASDAQ:AMED) edged lower by 1.2% after a judge tentatively set a date for the Dep. of Justice's challenge of ...

A sweeping fraud probe into UnitedHealth's Medicare Advantage payments sparks panic on Wall Street--Is this just the ...

UnitedHealth Group called The Wall Street Journal's report "misinformation" and said it was unaware of reported investigaiton ...

The U.S. Department of Justice has reportedly launched an investigation into UnitedHealth Group's (NYSE: UNH) Medicare ...

The probe is analyzing the company’s practice of frequently logging diagnoses that trigger larger payments to its Medicare ...

The U.S. Justice Department has launched an investigation into UnitedHealth's Medicare billing practices in recent months, ...

A trial between the Justice Department and UnitedHealth Group Inc. over its proposed purchase of Amedisys Inc. will take place in October 2025, a Maryland federal judge ruled Thursday.

The DOJ also sued UnitedHealth last November, preventing them from finalizing an over $3 billion acquisition of Amedisys, a ...

UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...

UnitedHealth Group (UNH) stock crashed on Friday morning in light of a new United States (US) Department of Justice (DOJ) ...

The justice department is examining how the insurer’s methods of recording patient diagnoses could result in excess payments to UnitedHealth’s Medicare Advantage plans, a privately run offshoot of the ...

Shares tumbled after The Wall Street Journal reported that the insurer is under Justice Department investigation.